ArticlePloS one2026
Valorization of waste pharmaceutical residues via pyrolysis: Simultaneous production of biochar for Cd2+ removal and high-quality bio-oil/syngas.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
For the efficient utilization of pharmaceutical waste resources, tuber biochar (TB) and herbal biochar (HB) were prepared via oxygen-limited slow pyrolysis at 500 °C for 3 h, using residues from tuber-type Xinsuning capsule and herbal-type Changyanning pill as the raw materials, respectively. The biochars were characterized by FESEM, BET, XRD and FTIR, and the feedstock physico-chemical properties were measured by common agricultural chemical analysis methods. The results revealed that both biochars possessed a high percentage of elemental O, a honeycomb-like porous structure, and surfaces enriched with functional groups such as hydroxyl, carboxyl, and carbonyl. HB exhibited a larger specific surface area and pore volume than TB, making it a more recommended carbon material. The chemical compositions of the pyrolysis by-products were systematically analyzed. The bio-oils were rich in ketones, alkanes, alcohols, olefins, fatty acids, phenols, and heterocyclic compounds, identifying them as potential sources of liquid fuels and chemical feedstocks. The most abundant components in bio-oils from tuber and herbal biomass were "Ethanol, 2,2-diethoxy-" (7.25%) and "Phosphonic acid, (p-hydroxyphenyl)-" (10.52%), respectively. The syngas has a low hydrogen content, is mainly pyrolysis off-gas and therefore has a limited application potential. Furthermore, the environmental application for Cd²⁺ removal was critically evaluated. Adsorption isotherms demonstrated high adsorption capacities, well-described by the Freundlich model (R² ≥ 0.99), indicating multilayer adsorption. The maximum adsorption capacities for TB and HB were 188.89 and 186.67 mg·g⁻¹, respectively. Kinetic studies revealed that the adsorption process followed the Elovich model (R² ≥ 0.98), suggesting heterogeneous diffusion, with HB achieving a higher equilibrium capacity (85.67 mg·g⁻¹) than TB (73.70 mg·g⁻¹). In conclusion, pyrolysis, particularly using herbal biomass, presents a promising strategy for the comprehensive and high-value utilization of waste pharmaceutical residues, simultaneously producing effective adsorbents for heavy metal remediation and valuable bio-energy products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.